UroGen Pharma

URGN • NASDAQ • Stock Fundamentals

UroGen Pharma is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Elizabeth A. Barrett, with a market cap of $1.4B.

Market Cap$1.4B

Employees204.0

CEOElizabeth A. Barrett

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 6, 2026 · 1 month 8 days agoQ1 2026

Next EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about UroGen Pharma

UroGen Pharma (URGN) has a market capitalization of $1.4B and trades on NASDAQ.

UroGen Pharma has approximately 204 employees.